Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANNA MANDALAKAS and ALEXANDER KAY.
ANNA MANDALAKAS
Connection Strength
12.183
ALEXANDER KAY
  1. Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study. Lancet Glob Health. 2024 06; 12(6):e929-e937.
    View in: PubMed
    Score: 0.871
  2. Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe. 2024 05; 5(5):e433-e441.
    View in: PubMed
    Score: 0.857
  3. Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
    View in: PubMed
    Score: 0.790
  4. Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting. Clin Infect Dis. 2022 05 03; 74(9):1631-1638.
    View in: PubMed
    Score: 0.754
  5. HIV-Associated Tuberculosis in Children and Adolescents: Evolving Epidemiology, Screening, Prevention and Management Strategies. Pathogens. 2021 Dec 29; 11(1).
    View in: PubMed
    Score: 0.736
  6. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV. PLoS One. 2020; 15(12):e0243713.
    View in: PubMed
    Score: 0.685
  7. It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg. 2020 10; 103(4):1348-1349.
    View in: PubMed
    Score: 0.675
  8. Evaluation of the QuantiFERON-Tuberculosis Gold Plus Assay in Children with Tuberculosis Disease or Following Household Exposure to Tuberculosis. Am J Trop Med Hyg. 2019 03; 100(3):540-543.
    View in: PubMed
    Score: 0.605
  9. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment. Curr Opin HIV AIDS. 2018 11; 13(6):501-506.
    View in: PubMed
    Score: 0.591
  10. Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis. PLOS Glob Public Health. 2025; 5(11):e0005243.
    View in: PubMed
    Score: 0.241
  11. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
    View in: PubMed
    Score: 0.240
  12. Performance of a Novel Stool Quantitative Polymerase Chain Reaction Assay for Pediatric Tuberculosis Detection in Sub-Saharan Africa. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.234
  13. Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens. Int J Tuberc Lung Dis. 2025 Mar 31; 29(4):189-192.
    View in: PubMed
    Score: 0.231
  14. Whispers in the Wind: Face Mask Sampling for Mycobacterium tuberculosis Detection in Children With Pulmonary Tuberculosis. J Infect Dis. 2024 Dec 16; 230(6):1510-1517.
    View in: PubMed
    Score: 0.226
  15. Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2024 Sep; 30(9):1123-1130.
    View in: PubMed
    Score: 0.209
  16. Community-based tuberculosis contact management: Caregiver experience and factors promoting adherence to preventive therapy. PLOS Glob Public Health. 2023; 3(7):e0001920.
    View in: PubMed
    Score: 0.205
  17. Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 Sep 20; 14(1):107.
    View in: PubMed
    Score: 0.194
  18. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
    View in: PubMed
    Score: 0.193
  19. The need for effective drugs for TB prevention: set your goals high, and don?t stop till you get there. Int J Tuberc Lung Dis. 2022 02 01; 26(2):85-88.
    View in: PubMed
    Score: 0.185
  20. Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents. Clin Infect Dis. 2021 08 02; 73(3):e580-e586.
    View in: PubMed
    Score: 0.179
  21. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev. 2021 06 28; 6:CD013693.
    View in: PubMed
    Score: 0.178
  22. Laboratory comparison of stool processing methods for Xpert? Ultra. Public Health Action. 2021 Jun 21; 11(2):55-57.
    View in: PubMed
    Score: 0.177
  23. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 04; 57(4).
    View in: PubMed
    Score: 0.175
  24. Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa. AIDS. 2021 01 01; 35(1):73-79.
    View in: PubMed
    Score: 0.172
  25. Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):543-552.
    View in: PubMed
    Score: 0.171
  26. Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa. Emerg Infect Dis. 2020 12; 26(12).
    View in: PubMed
    Score: 0.171
  27. Distinct Risk Factors for Clinical and Bacteriologically Confirmed Tuberculosis among Child Household Contacts in a High-Burden Setting. Am J Trop Med Hyg. 2020 12; 103(6):2506-2509.
    View in: PubMed
    Score: 0.169
  28. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 08 27; 8:CD013359.
    View in: PubMed
    Score: 0.168
  29. DNA hypermethylation during tuberculosis dampens host immune responsiveness. J Clin Invest. 2020 06 01; 130(6):3113-3123.
    View in: PubMed
    Score: 0.165
  30. Point-of-Care Testing to Guide Treatment and Estimate Risk Factors for Sexually Transmitted Infections in Adolescents and Young People With Human Immunodeficiency Virus in Eswatini. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa052.
    View in: PubMed
    Score: 0.162
  31. Diagnostic and Treatment Monitoring Potential of A Stool-Based Quantitative Polymerase Chain Reaction Assay for Pulmonary Tuberculosis. Am J Trop Med Hyg. 2018 08; 99(2):310-316.
    View in: PubMed
    Score: 0.142
  32. Leveraging tuberculosis case relative locations to enhance case detection and linkage to care in Swaziland. Glob Health Res Policy. 2018; 3:3.
    View in: PubMed
    Score: 0.140
  33. School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting. PLoS One. 2017; 12(6):e0178873.
    View in: PubMed
    Score: 0.134
  34. Estimating the Accuracy and Additionality of TB-LAM to Diagnose TB in Children Without HIV (AccuLAM). Clin Infect Dis. 2026 Feb 25; 82(2):301-303.
    View in: PubMed
    Score: 0.061
  35. An assessment of video-observed treatment as an adherence support tool for patients with drug-resistant TB. IJTLD Open. 2025 Dec; 2(12):763-768.
    View in: PubMed
    Score: 0.060
  36. Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiol Spectr. 2026 Jan 06; 14(1):e0233525.
    View in: PubMed
    Score: 0.060
  37. Gaps in TB-related knowledge and practices: An assessment of health care seeking behavior among adults with HIV and caregivers of paediatric patients with presumptive TB symptoms in Manhi?a district, southern Mozambique. PLOS Glob Public Health. 2025; 5(8):e0004734.
    View in: PubMed
    Score: 0.059
  38. TB elimination in Southern Africa: overview and critical reflection. IJTLD Open. 2025 Jul; 2(7):381-387.
    View in: PubMed
    Score: 0.059
  39. Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections. Nat Biomed Eng. 2026 Jan; 10(1):69-79.
    View in: PubMed
    Score: 0.059
  40. Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic Culture. Open Forum Infect Dis. 2025 Aug; 12(8):ofaf345.
    View in: PubMed
    Score: 0.059
  41. Healthcare providers' knowledge, attitudes, and perceptions from using targeted sequencing to diagnose and manage drug-resistant tuberculosis (DR-TB) in Eswatini. PLOS Glob Public Health. 2025; 5(6):e0004718.
    View in: PubMed
    Score: 0.058
  42. Perceived usability, acceptability, and feasibility of stool-based qPCR TB diagnostics: perspectives from healthcare providers in Manhi?a District, southern Mozambique. BMC Infect Dis. 2025 May 26; 25(1):757.
    View in: PubMed
    Score: 0.058
  43. Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study. Lancet Microbe. 2025 Jul; 6(7):101085.
    View in: PubMed
    Score: 0.058
  44. The catastrophic cost of TB care: Understanding costs incurred by individuals undergoing TB care in low-, middle-, and high-income settings - A systematic review. PLOS Glob Public Health. 2025; 5(4):e0004283.
    View in: PubMed
    Score: 0.058
  45. Rapid Diagnostic Sequencing of Stool DNA Using Targeted Nanopore Sequencing in Patients With a Pulmonary Tuberculosis Diagnosis. Open Forum Infect Dis. 2025 Apr; 12(4):ofaf121.
    View in: PubMed
    Score: 0.057
  46. Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysis. Lancet Microbe. 2025 Jun; 6(6):100963.
    View in: PubMed
    Score: 0.056
  47. Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
    View in: PubMed
    Score: 0.049
  48. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022 09; 10(9):e1307-e1316.
    View in: PubMed
    Score: 0.048
  49. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study. Lancet Microbe. 2022 07; 3(7):e482-e492.
    View in: PubMed
    Score: 0.047
  50. Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52.
    View in: PubMed
    Score: 0.047
  51. Sterilization of gowns: making the most of a scarce commodity during the COVID-19 pandemic. Public Health Action. 2021 Sep 21; 11(3):112-113.
    View in: PubMed
    Score: 0.045
  52. The Magnitude of Interferon Gamma Release Assay Responses in Children With Household Tuberculosis Contact Is Associated With Tuberculosis Exposure and Disease Status. Pediatr Infect Dis J. 2021 08 01; 40(8):763-770.
    View in: PubMed
    Score: 0.045
  53. Management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019 06 01; 23(6):645-662.
    View in: PubMed
    Score: 0.038
  54. Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies. Lancet Respir Med. 2019 06; 7(6):544-552.
    View in: PubMed
    Score: 0.038
  55. Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes. J Immunol. 2018 07 01; 201(1):124-133.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.